Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in NUVB — Nuvation Bio Inc.

CIK 1692234 Seattle, WA
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,751,548
+$1,611,699 QoQ
Shares Held
484,428
+82.3% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 242 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. NUVB ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in NUVB

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,751,548 484,428
2026-03-31 $1,139,849 265,700
2025-12-31 $219,125 24,456
2025-09-30 $76,866 20,775
2025-06-30 $202 104
2025-03-31 $27,975 15,895
2024-12-31 $42,280 15,895
2024-09-30 $238 104
2024-06-30 $262,984 90,064
2024-03-31 $122,227 33,579
2023-12-31 $57,499 38,079
2023-09-30 $43,621 32,553
2023-06-30 $47,037 26,132
2023-03-31 $43,379 26,132